###begin article-title 0
Interaction of the U3-55k protein with U3 snoRNA is mediated by the Box B/C motif of U3 and the WD repeats of U3-55k
###end article-title 0
###begin p 1
To whom correspondence should be addressed. Tel: +1 706 542 1896; Fax: +1 706 542 1752; Email: mterns@bchiris.bmb.uga.edu
###end p 1
###begin p 2
###xml 299 306 299 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 595 602 595 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 633 641 633 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 750 764 750 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis</italic>
###xml 1124 1131 1124 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 750 764 <span type="species:ncbi:8355">Xenopus laevis</span>
###xml 812 817 <span type="species:ncbi:9606">human</span>
U3 small nucleolar RNA (snoRNA) is a member of the Box C/D family of snoRNAs which functions in ribosomal RNA processing. U3-55k is a protein that has been found to interact with U3 but not other members of the Box C/D snoRNA family. We have found that interaction of the U3-55k protein with U3 RNA in vivo is mediated by the conserved Box B/C motif which is unique to U3 snoRNA. Mutation of Box B and Box C, but not of other conserved sequence elements, disrupted interaction of U3-55k with U3 RNA. Furthermore, a fragment of U3 containing only these two conserved elements was bound by U3-55k in vivo. RNA binding assays performed in vitro indicate that Box C may be the primary determinant of the interaction. We have cloned the cDNA encoding the Xenopus laevis U3-55k protein and find strong homology to the human sequence, including six WD repeats. Deletion of WD repeats or sequences near the C-terminus of U3-55k resulted in loss of association with U3 RNA and also loss of localization of U3-55k to the nucleolus, suggesting that protein-protein interactions contribute to the localization and RNA binding of U3-55k in vivo.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 424 425 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c1">1</xref>
###xml 426 427 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c6">6</xref>
###xml 592 593 592 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c7">7</xref>
###xml 594 595 594 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c8">8</xref>
###xml 713 714 713 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c7">7</xref>
###xml 715 716 715 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c8">8</xref>
###xml 939 940 939 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c9">9</xref>
Eukaryotic ribosome production requires the contribution of small nucleolar RNAs (snoRNAs) in the processing and modification of ribosomal RNA (rRNA). Involvement of snoRNAs in rRNA biogenesis includes the processing of the primary rRNA transcript into the mature 18S, 5.8S and 28S rRNAs, the methylation of selected ribose moieties (2' O-methylation) and the isomerization of specific uridine residues (pseudouridylation) (1-6). More than 150 snoRNAs have been identified and (with the exception of MRP RNA) are divided into two major classes: the Box C/D snoRNAs and the Box H/ACA snoRNAs (7,8). These two classes are distinguished by conserved sequence/secondary structure elements and by associated proteins (7,8). Both snoRNAs and their associated proteins are essential to the maturation of rRNA, indicating that the functional complexes in rRNA processing and modification are small nucleolar ribonucleoprotein particles (snoRNPs) (9).
###end p 4
###begin p 5
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c10">10</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c16">16</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c17">17</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c27">27</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c15">15</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c16">16</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c23">23</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c25">25</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c28">28</xref>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c17">17</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c19">19</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c23">23</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c25">25</xref>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c29">29</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c23">23</xref>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c27">27</xref>
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c30">30</xref>
###xml 969 971 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c23">23</xref>
###xml 972 974 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c27">27</xref>
###xml 975 977 975 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c30">30</xref>
###xml 1123 1130 1123 1130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1139 1141 1139 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c30">30</xref>
###xml 1231 1233 1231 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c31">31</xref>
U3 snoRNA is a Box C/D snoRNA essential for the processing of 18S rRNA from the pre-rRNA transcript (10-16). Sequence analysis of U3 snoRNA reveals six evolutionarily conserved sequence elements, termed Boxes A, A', B, C, C' and D (17-27). Boxes A and A' are located in the 5' domain of U3 snoRNA and, along with the 'hinge' region, base pair to sites within the pre-rRNA to direct the multiple endonucleolytic cleavages necessary for the maturation of 18S rRNA (15,16,23,25,28). Boxes B, C, C' and D are found in the 3' domain of U3 and have been characterized as sequences required for protein association (17,19,23,25,29). The secondary structure of the 3' domain positions Boxes B and C, as well as Boxes C' and D into discrete loops flanked by base paired stems to form the Box B/C and Box C'/D motifs, respectively (23,27,30). The Box C'/D motif of U3 is equivalent to the Box C/D motifs of other members of this snoRNA family in sequence/structure and function (23,27,30). The Box B/C motif is unique to U3 snoRNA. Both the Box B/C and Box C'/D motifs operate as independent units of U3 RNA nuclear retention in the Xenopus oocyte (30). The Box C'/D motif of U3 also directs the localization of the snoRNA to the nucleolus (31). The functions associated with the Box B/C and Box C'/D sequence motifs are very likely mediated by proteins that bind at these sites.
###end p 5
###begin p 6
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 45 47 45 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c20">20</xref>
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c32">32</xref>
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c33">33</xref>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c34">34</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c35">35</xref>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c36">36</xref>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c37">37</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c39">39</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c40">40</xref>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c41">41</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c42">42</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c43">43</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c44">44</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c44">44</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c29">29</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c39">39</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c41">41</xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c43">43</xref>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c44">44</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c46">46</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c47">47</xref>
###xml 965 967 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c29">29</xref>
###xml 977 983 977 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 1150 1158 1150 1158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1160 1162 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c29">29</xref>
###xml 1309 1311 1309 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 1319 1325 1319 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 1448 1455 1448 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1457 1459 1457 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 1685 1692 1685 1692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1694 1696 1694 1696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 1013 1018 <span type="species:ncbi:9606">human</span>
###xml 1230 1235 <span type="species:ncbi:9606">human</span>
###xml 1337 1342 <span type="species:ncbi:9606">human</span>
The U3 snoRNA exists as a U3 snoRNP in vivo (20,32,33). The RNA is associated with proteins common to all Box C/D snoRNAs, including fibrillarin/Nop1p (34,35), Nop56p (36) and Nop58/Nop5p (37-39) and proteins specific to the U3 snoRNP, including Sof1p (supressor of fibrillarin; 40), Mpp10 (41,42), Lcp5p (43), Imp3p (44), Imp4p (44) and U3-55k (29,45). Each of these proteins (like U3 RNA) are essential and have been shown to be specifically required for the maturation of 18S rRNA [39-41,43,44,46,47, and J.Venema and H.A.Raue (Vrije Universiteit, Amsterdam, The Netherlands) personal communication]. U3-55k, the focus of this work, was initially identified as part of a trimeric complex (p55, p50 and p15) that co-purified from CHO cells with U3 snoRNA. The co-purification of the trimeric complex with U3 snoRNA was carried out under conditions of high salt (650 mM KCl or 500 mM NaCl), suggesting that the three proteins are core components of the U3 snoRNP (29). Lubben et al. analyzed deletion mutants of human U3 RNA and determined that a central region of the RNA (nt 97-204) was important for binding of a complex that included CHO U3-55k in vitro (29). The cDNA for the U3-55k protein was subsequently isolated from a human teratocarcinoma library and the protein was characterized in HeLa cells (45). Pluk et al. found that human U3-55k (hU3-55k) co-localized with fibrillarin in nucleoli and showed the association of hU3-55k with U3 in vivo (45). In addition, characterization of several hU3-55k mutants revealed that replacement of 17 amino acids at the C-terminus disrupted localization of the protein to nucleoli and the ability of U3-55k to associate with U3 snoRNA in vivo (45).
###end p 6
###begin p 7
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 99 104 99 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink">23&#8211;41</sub>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c48">48</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c50">50</xref>
###xml 347 349 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c51">51</xref>
###xml 350 352 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c53">53</xref>
###xml 601 603 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c54">54</xref>
###xml 604 606 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c57">57</xref>
U3-55k belongs to the WD repeat family of proteins (45), characterized by the core sequence [GH]-(X23-41)-[WD] arranged in repeats of four to eight units (48-50). beta-Transducin (Gbeta), a member of the same family, has seven WD repeats which fold into a propeller-like structure with each repeat motif forming a discrete blade of the propeller (51-53). Although Gbeta is the only WD repeat protein whose structure has been determined by crystallography, structural analysis and homology modeling of other WD proteins indicate that the propeller structure may be common to the members of the family (54-57). The structure appears to provide a platform on which protein-protein interactions can occur, with the specificity of these interactions being directed by variable sequences within each WD repeat.
###end p 7
###begin p 8
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c49">49</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c40">40</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c58">58</xref>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c64">64</xref>
WD repeat proteins have been found to function in a variety of processes (49). Several WD repeat proteins in addition to U3-55k (e.g. PRP4, PRP17, U5-40kD and Sof1) have been found to be associated with specific RNAs (40,58-64). Like U3-55k, these proteins do not contain known RNA binding motifs and it remains to be determined whether these proteins interact directly with the associated RNAs.
###end p 8
###begin p 9
###xml 21 28 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 151 158 151 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 163 171 163 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 282 289 282 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 291 299 291 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
We have isolated the Xenopus homolog of U3-55k (XlU3-55k) and characterized the sequences of Xenopus U3 RNA important for interaction with U3-55k both in vivo and in vitro. Our results indicate that the Box B/C motif of U3 snoRNA is both necessary and sufficient for U3-55k binding in vivo. In vitro analysis suggests that Box C is of greater importance than Box B in the interaction between U3 and U3-55k. In addition, we have examined the effects of deletion of regions of hU3-55k on nucleolar localization of the protein and U3 snoRNP assembly. While nuclear localization sequences and a glutamic acid-rich region near the N-terminus are not required, our results indicate that the WD repeats and specific sequences near the C-terminus of hU3-55k are required for localization to the nucleolus and interaction with U3 snoRNA.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
###xml 15 29 15 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus laevis</italic>
###xml 15 29 <span type="species:ncbi:8355">Xenopus laevis</span>
Cloning of the Xenopus laevis U3-55k
###end title 11
###begin p 12
###xml 186 192 186 192 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GAATTC</underline>
###xml 198 204 198 204 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GAATTC</underline>
###xml 204 207 204 207 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ATG</bold>
###xml 251 257 251 257 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GAATTC</underline>
The oligonucleotides used in the cloning of XlU3-55k were: 84, GAGCTGGARGARACYGCACAGGAAAAGAA; 85, TTCTCCACCATCGGCCAAGCCTGTGCTC; 111, CAATGGCATCCTGATCCTCG; 124, CTGGGATCCTCTGACATG; 166, GGAATTCCATATGGAATTCATGTCCGGCCTTTTCATCAAAAAGAAATCAGG; 167, GAAGATCTGAATTCGTGCAACAGGGTCAACAAAATATGTCTATGTGG.
###end p 12
###begin p 13
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 160 168 160 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X.laevis</italic>
###xml 566 573 566 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 832 835 832 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 1008 1015 1008 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 160 168 <span type="species:ncbi:8355">X.laevis</span>
###xml 304 309 <span type="species:ncbi:9606">human</span>
###xml 349 354 <span type="species:ncbi:10090">mouse</span>
###xml 383 388 <span type="species:ncbi:4932">yeast</span>
The Xenopus homolog of hU3-55k was isolated using a combination of RT-PCR and rapid amplification of cDNA ends (RACE) against mRNA isolated from stage V and VI X.laevis oocytes (mRNA Separator Kit, Clontech, CA). Degenerate oligonucleotides, 84 and 85, were designed based on sequences conserved between human (accession no. AJ001340) and potential mouse (accession no. AA170033) or yeast (accession no. U40829, ORF: YPR137W) U3-55k sequences, respectively, and used in RT-PCR (Boehringer Mannheim, Indianapolis, IN) to amplify an internal fragment (1090 bp) of the Xenopus U3-55k cDNA. Primers 111 and 124 were used in RACE to isolate the 5' and 3' ends of the cDNA, respectively (Marathon-Ready cDNA, Clontech, and 3' RACE system, Gibco BRL, MD). Primers 166 (start codon in bold) and 167 (3'-UTR) were designed with incorporated EcoRI sites (underlined) immediately flanking the predicted protein coding region. Using these primers, RT-PCR was used to isolate the full-length (1451 bp) cDNA from purified Xenopus oocyte mRNA and the product was subcloned and sequenced.
###end p 13
###begin title 14
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
Expression of recombinant Xenopus U3-55k and production of antibodies
###end title 14
###begin p 15
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 136 139 136 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 230 246 230 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 635 636 631 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 230 251 <span type="species:ncbi:511693">Escherichia coli BL21</span>
###xml 427 433 <span type="species:ncbi:9986">rabbit</span>
The Xenopus U3-55k cDNA was excised by digestion at the engineered EcoRI sites flanking the encoding cDNA, and cloned in frame into the EcoRI site of the pET32a expression vector (Novagen, WI). The fusion protein was expressed in Escherichia coli BL21(DE3) and isolated by nickel chelation affinity chromatography under denaturing conditions (His-Bind Resin and Buffer Kit, Novagen) and gel purification. One New Zealand white rabbit was immunized with 250 microg of the purified recombinant protein (Animal Resources, University of Georgia, Athens, GA). Antibodies were affinity purified using purified XlU3-55k protein coupled to an N-hydroxysuccinimide-activated Sepharose column (HiTrap, Amersham Pharmacia Biotech, Piscataway, NJ).
###end p 15
###begin title 16
U3 snoRNA mutant constructs
###end title 16
###begin p 17
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c31">31</xref>
Construction of the Xenopus U3 snoRNA single box substitutions A, A', B, C, C' and D, the 3' domain sub-fragment (nt 75-220), the C'/D sub-fragment (nt 75-104, tetraloop GCUU, nt 198-220) and B/C sub-fragment (nt 93-208) has been detailed (31).
###end p 17
###begin title 18
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
Injection of RNAs into Xenopus oocytes
###end title 18
###begin p 19
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c30">30</xref>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c31">31</xref>
###xml 119 121 119 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 259 267 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X.laevis</italic>
###xml 432 433 422 423 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 464 465 454 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 480 481 470 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 482 483 472 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 497 498 487 488 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 259 267 <span type="species:ncbi:8355">X.laevis</span>
The procedure for microinjection of Xenopus oocyte nuclei has been described in detail (30,31). In short, a mixture of 32P-labeled RNAs was resuspended in 20 mg/ml of blue dextran (at a final concentration of 100 fmol/microl U3 snoRNA). Nuclear injections of X.laevis oocytes (stages V and VI) delivered 10 nl (1 fmol of U3) of sample and cells were incubated for 4 h at 18degreesC in MBSH buffer [88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 20 mM HEPES pH 7.5, 0.82 MgSO4, 0.33 mM Ca(NO3)2, 0.41 mM CaCl2, containing 10 microg/ml of penicillin and streptomycin]. After incubation, nuclear extracts were prepared by manual enucleation of injected oocytes and homogenized in Ipp100-T buffer (100 mM NaCl, 50 mM Tris-HCl, pH 7.5, and 0.05% Triton X-100).
###end p 19
###begin title 20
Construction of hU3-55k deletion mutants
###end title 20
###begin p 21
###xml 97 103 97 103 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGATCC</underline>
###xml 147 153 147 153 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGATCC</underline>
###xml 195 201 195 201 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGATCC</underline>
###xml 245 251 245 251 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGATCC</underline>
###xml 295 301 295 301 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGATCC</underline>
###xml 348 354 348 354 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGATCC</underline>
###xml 399 405 399 405 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGATCC</underline>
###xml 450 456 450 456 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGATCC</underline>
###xml 499 505 499 505 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGATCC</underline>
###xml 551 557 551 557 <underline xmlns:xlink="http://www.w3.org/1999/xlink">GGATCC</underline>
###xml 751 754 743 746 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TGA</bold>
###xml 754 760 746 752 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TCTAGA</underline>
###xml 796 799 788 791 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TGA</bold>
###xml 799 805 791 797 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TCTAGA</underline>
The oligonucleotides used to generate hU3-55k deletion mutants were: 55k140-For, GCCTCAGCTGACATTCGGATCCTACGGGGGCACCAGC; 55k140-Rev, GCTGGTGCCCCCGTAGGATCCGATGTCAGCTGAGGC; 55k193-For, GAAGGGTGCCGAGGGATCCCCCCCTGGCCACAGC; 55k193-Rev, GCTGTGGCCAGGGGGGGATCCCTCGGCACCCTTC; 55k230-For, CATTTGGGAGGCCCAGAGGATCCAGCACTTGTACACCTTC; 55k230-Rev, GAAGGTGTACAGTGCTGGATCCTCTGGGCCTCCCAAATG; 55k315-For, GGAAGATCCCCGAGGGATCCCAGCTTGTCTTCTATG; 55k315-Rev, CATAGAAGACAAGCTGGATCCCTCGGGGATCTTCC; 55k352-For, GTGGCCTTGTGGGGTGGATCCAAGAAGCGACCACTTG; 55k352-Rev, CAAGTGGTCGCTTCTTGGATCCACCCCACAAGGCCAC; 55kDeltaE-For, GCCTAGCTCCAAGGAAGCCTACTGCACAGGAAAAGAAGCTG; 55kDeltaE-Rev, CAGCTTCTTTTCCTGTGCAGTAGGCTTCCTTGGAGCTAGGC; 55kA, GCAGCCCTTCTGGATATCGTCGG; 55kB, AGAATCAAAGAGGCTCGGAATTCTTGATCTAGAGCG; and 55kC, TGCATCATCCCACTCCGCAGGTGATCTAGAGCG.
###end p 21
###begin p 22
###xml 46 48 46 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 113 116 113 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
pCI-neo VSV-55k was constructed as described (45). The original hU3-55k cDNA was modified by PCR to introduce an XhoI site before the translational start codon [pGEM3Zf(+)-hU3-55k (45)].
###end p 22
###begin p 23
###xml 320 323 304 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 521 524 501 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 611 614 583 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 621 624 593 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 682 685 654 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 692 695 664 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 944 947 904 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 954 957 914 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nar</italic>
###xml 1081 1084 1041 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 1091 1094 1051 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nar</italic>
###xml 1221 1224 1177 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 1292 1295 1248 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 1355 1358 1307 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 1364 1367 1316 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sma</italic>
The hU3-55k deletion mutants Delta459-475, Delta467-475 and Delta64-74 were generated via mutagenic PCR using pGEM 3Zf(+)-hU3-55k as template. Deletion mutant Delta459-475 was made using oligonucleotides 55kA and 55kB which incorporate a stop codon (indicated in bold) at amino acid position 458 followed by an in-frame XbaI restriction site (underlined). Deletion mutant Delta467-475 was made using oligonucleotides 55kA and 55kC which incorporate a stop codon (bold) at amino acid position 466, followed by an in-frame XbaI site (underlined). The Delta459-475 and Delta467-475 PCR products were digested with EcoRV and XbaI and cloned into wild-type pCI-neo VSV-55k digested with EcoRV and XbaI. Deletion mutant Delta64-74 was generated by PCR (QuickChange site-directed mutagenesis kit, Stratagene, The Netherlands) using oligonucleotides 55kDeltaE-For and 55kDeltaE-Rev and pGEM3Zf(+)-hU3-55k as template. The PCR product was digested with BglII and NarI and the 180 bp product, which lacked the E-stretch, was cloned into the wild-type pGEM3Zf(+)-hU3-55k vector digested with BglII and NarI, thereby replacing the wild-type sequence. The resulting construct, pGEM3Zf(+)-hU3-55kDeltaE, was subsequently digested with HindIII, made blunt with Klenow polymerase and partially digested with XhoI. The resulting hU3-55kDeltaE fragment was ligated into an XhoI and SmaI-digested pCI-neo vector that contains a 5' VSV-G tag (MEIYTDIEMNRLGK). The resulting construct contained a 5' VSV tag in-frame with the coding sequence of hU3-55k.
###end p 23
###begin p 24
###xml 319 322 319 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 539 542 535 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 544 547 540 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 578 581 574 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 584 587 580 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 657 660 649 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 662 665 654 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 696 699 688 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 702 705 694 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 775 778 763 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 780 783 768 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 814 817 802 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 820 823 808 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
To construct the hU3-55k WD deletion mutants, PCR mutagenesis was performed on the pGEM3Zf(+)-hU3-55k cDNA using appropriate combinations of the oligonucleotides listed above (QuickChange site-directed mutagenesis kit). In-frame deletions of WD repeats were generated from five pGEM3Zf(+)-55k constructs that contain a BamHI site (underlined) at nucleotide positions 452 (55k452), 610 (55k610), 723 (55k723), 977 (55k977) or 1087 (55k1087), corresponding to amino acids 140, 193, 230, 315 or 352. 55kDelta140-230 was made by combining the XhoI-BamHI fragment of 55k452 with the BamHI-HindIII fragment of 55k723. 55kDelta193-315 was created by combining the XhoI-BamHI fragment of 55k610 with the BamHI-HindIII fragment of 55k977. 55kDelta193-352 was created by combining the XhoI-BamHI fragment of 55k610 with the BamHI-HindIII fragment of 55k1087.
###end p 24
###begin p 25
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 145 148 145 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 204 207 204 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 213 216 213 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sma</italic>
Finally, all pGEM3Zf(+)-55k deletion mutant constructs were digested with HindIII, made blunt with Klenow polymerase and partially digested with XhoI. The resulting hU3-55k fragments were ligated into an XhoI and SmaI-digested pCI-neo vector. The resulting constructs contained a 5' VSV tag in-frame with the coding sequence of hU3-55k. The correctness of each construct was confirmed by sequence analysis.
###end p 25
###begin title 26
Expression of hU3-55k constructs in COS-1 and HEp-2 cells
###end title 26
###begin p 27
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 361 362 349 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 659 663 <span type="species:ncbi:9913">calf</span>
hU3-55k constructs were transiently transfected into cultured cells. Monolayers of cells were grown to 80% confluence. COS-1 cells (4-5 x 106) were transfected in 400 microl phosphate-buffered saline (PBS) with 20 microg DNA. Electroporation was performed at 300 V and a capacity of 125 microFa with Gene Pulser II (Bio-Rad, Richmond, CA). HEp-2 cells (2.5 x 106) were transfected in 800 microl of Dulbecco's modified Eagle's medium (DMEM) with 10 microg of DNA. Electroporation was performed at 260 V and a capacity of 950 microFa with Gene Pulser II (Bio-Rad). After electroporation, cells were resuspended in 5 or 10 ml of DMEM supplemented with 10% fetal calf serum and grown for 18 h before use.
###end p 27
###begin title 28
Immunoblot analysis
###end title 28
###begin p 29
###xml 0 70 0 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of Xenopus nuclear proteins with antibodies against XlU3-55k.</italic>
###xml 146 153 146 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 717 723 <span type="species:ncbi:9986">rabbit</span>
Analysis of Xenopus nuclear proteins with antibodies against XlU3-55k. Nuclear samples were prepared by manual dissection of nuclei from stage VI Xenopus oocytes and were electrophoresed on a 10% SDS-polyacrylamide gel with five nuclear equivalents per lane. Proteins were transferred to nitrocellulose (Bio-Rad). Immobilized proteins were blocked for 1 h with 5% non-fat milk in TBS (100 mM Tris, 0.9% NaCl, pH 7.5) and washed three times in TBS. Pre-immune serum was diluted 1:100 and affinity purified alphaXlU3-55k antibodies (approximately2 microg/microl) were diluted 1:2000 in TTBS (0.5% Tween-20 in TBS), and incubated with membranes for 1 h at room temperature. Membranes were washed and incubated with anti-rabbit IgG (whole molecule) alkaline phosphatase conjugated antibodies (Sigma, St Louis, MO) at a dilution of 1:5000 in TTBS for 1 h at room temperature. After washing, immunoreactive proteins were visualized by incubation with NBT/BCIP (Sigma) for 10 min.
###end p 29
###begin p 30
###xml 0 64 0 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of expression of VSV-hU3-55k constructs in COS-1 cells.</italic>
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 528 534 <span type="species:ncbi:9986">rabbit</span>
###xml 627 638 <span type="species:ncbi:3704">horseradish</span>
###xml 662 666 <span type="species:ncbi:9925">goat</span>
###xml 672 677 <span type="species:ncbi:10090">mouse</span>
Analysis of expression of VSV-hU3-55k constructs in COS-1 cells. Extract prepared from 1.0 x 106 COS-1 cells was acetone precipitated, the proteins resolved by 10% SDS-PAGE and blotted to a nitrocellulose membrane (Protan, Schleicher & Schuell, Dassel, Germany). After 1 h incubation in blocking buffer (5% non-fat milk, 0.1% NP-40, in PBS), the blot was incubated with anti-VSV antibodies (Boehringer Mannheim, Almere, The Netherlands) diluted 1:50 in buffer B (3% non-fat milk, 0.1% NP-40, in PBS) supplemented with 1% normal rabbit serum for 1 h at room temperature. The blot was washed in buffer B, and then incubated with horseradish peroxidase-conjugated, goat anti-mouse antibodies (Dako, Denmark) for 1 h at room temperature. After washing, bound secondary antibodies were visualized via chemiluminescence.
###end p 30
###begin title 31
Immunofluorescence analysis
###end title 31
###begin p 32
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of X1U3-55k in Xenopus</italic>
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells.</italic>
###xml 94 101 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c31">31</xref>
###xml 153 160 153 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 214 215 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 293 298 <span type="species:ncbi:9796">horse</span>
###xml 590 596 <span type="species:ncbi:9986">rabbit</span>
Analysis of X1U3-55k in Xenopuscells. Indirect immunofluorescence analysis was carried out on Xenopus oocyte nuclear spreads as described (31). Briefly, Xenopus nuclear contents were centrifuged onto a slide (5140 g for 1 h), fixed with 1% paraformaldehyde in PBS for 1 h and blocked with 10% horse serum (Hyclone, Logan, UT) in PBS for 15 min at 37degreesC. Slides were washed and incubated with pre-immune serum (diluted 1:1000 in PBS) or affinity purified alphaXlU3-55k antibodies (diluted 1:1000 in PBS) for 1 h at 37degreesC. Slides were washed and incubated with FITC-conjugated anti-rabbit antibody (Jackson ImmunoResearch, PA) at 1:50 dilution in PBS for 1 h at 37degreesC. Slides were washed and mounted with 50% glycerol in PBS containing 1 mg/ml phenylenediamine, pH 9.0.
###end p 32
###begin p 33
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 584 590 <span type="species:ncbi:9986">rabbit</span>
For indirect immunofluorescence of Xenopus somatic cells, XlK2 cells were grown on autoclaved glass slides to approximately80% confluence. Slides were rinsed in PBS and fixed for 10 min in 5% paraformaldehyde in PBS at 25degreesC. Cells were permeabilized in acetone (pre-chilled at -20degreesC) for 5 min, rinsed and blocked in 3% BSA in PBS for 1 h at room temperature. Slides were rinsed and incubated with pre-immune serum (diluted 1:1000) or affinity purified antibodies (diluted 1:20 000) in 3% BSA in PBS for 1 h at 37degreesC. Slides were washed and Texas Red-conjugated anti-rabbit antibodies (Jackson Immunoresearch) were added at 1:50 dilution in 3% BSA in PBS and incubated for 45 min at room temperature. Slides were washed and mounted as described above.
###end p 33
###begin p 34
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
Analysis of Xenopus oocyte nuclear spreads and kidney cells was carried out on a Zeiss Axiovert S 100 inverted fluorescence microscope equipped with differential interference contrast optics (Thornwood, NY). Images were acquired at 63x magnification using a cooled charge-coupled device camera (Quantix-Photometrix, AZ) and IP Lab Spectrum software (Signal Analytics, VA).
###end p 34
###begin p 35
###xml 0 48 0 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of VSV-hU3-55k proteins in HEp-2 cells.</italic>
###xml 336 338 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c65">65</xref>
###xml 491 497 <span type="species:ncbi:9986">rabbit</span>
###xml 580 584 <span type="species:ncbi:9925">goat</span>
###xml 590 595 <span type="species:ncbi:10090">mouse</span>
Analysis of VSV-hU3-55k proteins in HEp-2 cells. Transiently transfected HEp-2 cells were grown for 18 h. The slides were washed with PBS, placed in methanol for 5 min at -20degreesC and permeabilized with acetone for 1 min at room temperature. Indirect immunofluorescence was performed using monoclonal anti-fibrillarin antibody 72B9 (65) and monoclonal anti-VSV antibody (Boehringer Mannheim, Almere, The Netherlands) diluted 1:2 and 1:50, respectively, in PBS supplemented with 1% normal rabbit serum. Fixed cells were incubated with monoclonal antibodies for 1 h, followed by goat anti-mouse antibodies coupled to fluorescein isothiocyanate (Dako; diluted 1:50 in PBS) for 1 h.
###end p 35
###begin p 36
Images were aquired using an Olympus BH2 microscope (Olympus, Hamburg, Germany) in combination with an Olympus DP10 microscope digital camera system and analySIS sofware (Soft Imaging System GMBH, Munster, Germany)
###end p 36
###begin title 37
Immunoprecipitations
###end title 37
###begin p 38
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus U3-55k.</italic>
Xenopus U3-55k. Antiserum against XlU3-55k (10 microl/immunoprecipitation) was coupled to protein A-Sepharose CL-4C beads (Sigma) in 0.5 ml of Ipp 500 buffer (500 mM NaCl, 50 mM Tris-HCl, pH 7.5, and 0.1% NP-40) at 4degreesC overnight. Immunoprecipitations were performed with nuclear extracts isolated from injected oocytes (three nuclei/immunoprecipitation) in Ipp100-T. Samples were incubated overnight at 4degreesC in the presence of 40 U RNasin (Promega, Madison, WI) and 2 mM dithiothreitol (DTT). RNA from supernatants and pellets was isolated by proteinase K digestion, phenol extraction and ethanol precipitation. Precipitated RNAs were separated by 8% urea-PAGE and visualized by autoradiography.
###end p 38
###begin p 39
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Human U3-55k.</italic>
###xml 378 379 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 948 949 912 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 1216 1217 1174 1175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1377 1379 1335 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 1380 1382 1338 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c66">66</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 445 451 <span type="species:ncbi:9986">Rabbit</span>
###xml 457 462 <span type="species:ncbi:10090">mouse</span>
Human U3-55k. After 18 h of growth, transfected COS-1 cells were washed with PBS and resuspended in buffer A [25 mM Tris-HCl, pH 7.5, 100 mM KCl, 1 mM DTE (1,4-dithioerythritol), 2 mM EDTA, 0.5 mM PMSF, 0.05% NP-40] to approximately1000 cells/microl. The cell suspension was sonicated with a Branson microtip (three times for 20 s each), insoluble material was pelleted (12 000 g, 15 min) and the supernatants were used for immunoprecipitation. Rabbit anti-mouse antibodies (Dako) were coupled to 10 microl of protein A agarose beads (Biozym, Landgraaf, The Netherlands) in IPB500 (500 mM NaCl, 10 mM Tris-Cl, pH 8.0, 0.05% NP-40). The beads were washed with IPB500 and then incubated with monoclonal anti-VSV and anti-fibrillarin antibodies for 1 h at room temperature. The beads were subsequently washed twice with IPB500 and once with IPB150 (150 mM NaCl, 10 mM Tris-Cl, pH 8.0, 0.05% NP-40) and 250 microl of cell extract (approximately2.5 x 105 cells) was added and incubated for 1 h at 4degreesC. After washing three times with IPB150, RNA was isolated from the beads by phenol-chloroform extraction and ethanol precipitation. RNA was resolved on an 8% denaturing polyacrylamide gel and blotted onto a Hybond-N+ membrane (Amersham, Buckinghamshire, UK). Northern analysis performed with anti-sense radiolabeled U3 RNA probes was done essentially as previously described (45,66).
###end p 39
###begin title 40
###xml 46 54 46 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Analysis of U3-55k association with U3 snoRNA in vitro
###end title 40
###begin p 41
###xml 210 218 210 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 231 233 231 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 379 381 379 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 534 542 526 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 805 806 785 786 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 273 278 <span type="species:ncbi:4565">wheat</span>
###xml 305 310 <span type="species:ncbi:4565">Wheat</span>
###xml 619 624 <span type="species:ncbi:4932">yeast</span>
Biotinylated RNAs were synthesized using a 10:1 ratio of UTP to UTP-21-biotin (Clontech) and the yield estimated by ethidium bromide staining (to allow addition of comparable amounts of each RNA to reactions). In vitro translated, 35S-labeled hU3-55k was synthesized using wheat germ extract (TNT Coupled Wheat Germ Extract System, Promega) in the presence of translation grade [35S]methionine (1000 Ci/mmol; Amersham, NJ). Approximately 5% of the biotinylated RNA made in a 25 microl transcription reaction was added to 10 microl of in vitro translated hU3-55k, 40 U RNasin (Promega), 2 microg non-specific competitor yeast tRNA (Boehringer Mannheim, IN), and 2 microl of 10x binding assay buffer (100 mM Tris, pH 8.0, 1 M KCl and 0.5% NP-40). Reactions were brought to a final volume of 20 microl with H2O and allowed to incubate for 1 h at 4degreesC. After incubation, 10 microl of streptavidin agarose beads (Gibco BRL, Grand Island, NY) were added and the final volume was brought to 500 microl with 1x binding assay buffer. Samples were incubated for 1 h at 4degreesC. After incubation, pellets were washed three times with 1 ml ice-cold 1x binding assay buffer and resuspended in SDS-PAGE loading buffer. Samples were boiled and resolved by 12% SDS-PAGE. Gels were fixed in water:isopropanol:glacial acetic acid (65:25:10) for 30 min, incubated in Amplify (Amersham, NJ) for an additional 30 min, dried and exposed to film at -80degreesC.
###end p 41
###begin title 42
RESULTS
###end title 42
###begin title 43
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
Isolation and characterization of Xenopus U3-55k
###end title 43
###begin p 44
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c29">29</xref>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 180 187 180 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 199 206 199 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 255 263 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X.laevis</italic>
###xml 287 294 287 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 579 586 579 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f1">1</xref>
###xml 667 674 667 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 880 882 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 916 917 904 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f1">1</xref>
###xml 1002 1009 990 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1023 1024 1011 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f1">1</xref>
###xml 1110 1117 1098 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1211 1218 1199 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1271 1285 1259 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Caenorhabditis</italic>
###xml 1285 1292 1273 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">elegans</italic>
###xml 1380 1387 1368 1375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1532 1534 1520 1522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 1580 1587 1568 1575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1596 1603 1584 1591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 1798 1806 1786 1794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X.laevis</italic>
###xml 1834 1841 1822 1829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 77 82 <span type="species:ncbi:9606">human</span>
###xml 255 263 <span type="species:ncbi:8355">X.laevis</span>
###xml 394 399 <span type="species:ncbi:9606">human</span>
###xml 442 447 <span type="species:ncbi:10090">mouse</span>
###xml 452 457 <span type="species:ncbi:4932">yeast</span>
###xml 624 629 <span type="species:ncbi:9606">human</span>
###xml 634 639 <span type="species:ncbi:4932">yeast</span>
###xml 743 748 <span type="species:ncbi:9606">human</span>
###xml 791 796 <span type="species:ncbi:4932">yeast</span>
###xml 992 997 <span type="species:ncbi:9606">human</span>
###xml 1036 1041 <span type="species:ncbi:4932">yeast</span>
###xml 1100 1105 <span type="species:ncbi:9606">human</span>
###xml 1201 1206 <span type="species:ncbi:9606">human</span>
###xml 1374 1379 <span type="species:ncbi:9606">human</span>
###xml 1714 1719 <span type="species:ncbi:9606">human</span>
###xml 1724 1729 <span type="species:ncbi:4932">yeast</span>
###xml 1798 1806 <span type="species:ncbi:8355">X.laevis</span>
###xml 1846 1851 <span type="species:ncbi:9606">human</span>
U3-55k has been found to interact specifically with U3 snoRNA in hamster and human cells (29,45). In order to determine the U3 RNA sequences required for the association of U3-55k in vivo (using the Xenopus oocyte system), we cloned the cDNA encoding the X.laevis homolog of U3-55k. The Xenopus clone was identified by RT-PCR using degenerate oligonucleotide primers based on alignments of the human U3-55k (45) with sequences from potential mouse and yeast homologs present in the GenBank/EMBL sequence database (Materials and Methods). The predicted amino acid sequence of the Xenopus homolog, XlU3-55k, is shown with the human and yeast sequences in Figure 1. The Xenopus U3-55k protein is approximately65% identical and 73% similar to the human, but 41% identical and 54% similar to the yeast homolog. The positions of each of five WD repeats initially identified in hU3-55k (45) are conserved in XlU3-55k (Fig. 1, WD1-5). In addition, we report the presence of a sixth WD repeat in both human and Xenopus U3-55k (Fig. 1, WD6). The yeast U3-55k contains stretches of amino acids not found in the human and Xenopus proteins (e.g. between WD4 and WD5) and shares five of the six WD repeats found in human and Xenopus (WD2-6) but lacks a WD consensus sequence at WD1. A Caenorhabditiselegans homolog of U3-55k (CE21137) contains four of the six WD repeats corresponding to human/Xenopus WD3-6 (R.Terns and M.Terns, unpublished data). Putative nuclear localization signals were identified within the first 45 amino acids of U3-55k (45) and these signals appear to be conserved in Xenopus U3-55k. Xenopus U3-55k also contains a glutamic acid-rich region near the N-terminus (amino acids 60-65) that is found in the human and yeast homologs. The sequence analysis indicates that we have isolated the X.laevis homolog of U3-55k and that Xenopus and human U3-55k each contain six potential WD domains.
###end p 44
###begin p 45
###xml 38 44 38 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 204 211 192 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 241 242 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f2">2</xref>
###xml 329 336 317 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 354 361 342 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 419 420 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f2">2</xref>
###xml 38 44 <span type="species:ncbi:110766|species:ncbi:562">E.coli</span>
The XlU3-55k protein was expressed in E.coli and used to generate antibodies (Materials and Methods). The affinity purified antibodies recognize an approximately60 kDa protein by western blot analysis of Xenopus oocyte nuclear extract (Fig. 2A). We assessed the cellular localization of XlU3-55k in nuclear spreads prepared from Xenopus oocytes and in a Xenopus somatic cell line using the alphaU3-55k antibodies (Fig. 2B and C). The immunofluorescence analysis revealed that XlU3-55k is present in the nucleoli of both cell types.
###end p 45
###begin title 46
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Analysis of U3 RNA sequences required for U3-55k association in vivo
###end title 46
###begin p 47
###xml 124 131 124 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 168 175 168 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 260 267 260 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 530 531 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f3">3</xref>
###xml 813 814 809 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f3">3</xref>
###xml 1116 1117 1108 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f3">3</xref>
###xml 1234 1235 1218 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f3">3</xref>
###xml 1407 1414 1371 1378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
We have used the antibodies against XlU3-55k to investigate the sequences in U3 snoRNA required for interaction with U3-55k in vivo. In these experiments, radiolabeled Xenopus U3 and control RNAs (U1 and U6 snRNAs, U8 snoRNA and 5S rRNA) were co-injected into Xenopus oocytes and allowed to incorporate into RNP complexes. Four hours after injection, RNP complexes containing U3-55k were immunoprecipitated from oocyte nuclear extracts. The alphaU3-55k antibodies specifically immunoprecipitated a complex containing U3 RNA (Fig. 3, lane 5). In order to determine which conserved U3 RNA sequence elements are necessary for interaction with U3-55k, we substituted the sequence of each of the phylogenetically conserved U3 Box elements, A, A', B, C, C' and D as well as the hinge with complementary sequences (Fig. 3, Delta indicates substitution). Each of the radiolabeled U3 mutant RNAs was co-injected with the control RNAs and tested for interaction with the U3-55k protein by immunoprecipitation. We found that substitution of the Box B or C elements of U3 RNA disrupted association with the U3-55k protein (Fig. 3, U3DeltaB and U3DeltaC, lanes 19-24). Substitution of the other sequence elements did not prevent interaction (Fig. 3, U3DeltaA', U3DeltaA, U3DeltaH, U3DeltaC' and U3DeltaD, lanes 7-18, 25-27). The results indicate that Boxes B and C of U3 snoRNA are necessary for interaction with U3-55k in vivo.
###end p 47
###begin p 48
###xml 335 342 335 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f4">4</xref>
###xml 523 524 523 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f4">4</xref>
###xml 677 678 673 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f4">4</xref>
###xml 767 774 763 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
In order to assess whether the Box B/C motif of U3 RNA is also sufficient for U3-55k binding, we tested the ability of stable fragments of U3 RNA to interact with U3-55k. Again, radiolabeled RNAs were injected and interaction was assessed by immunoprecipitation. A fragment consisting of the entire 3' domain of U3 was bound by U3-55k in vivo (Fig. 4, 3' Domain, lanes 1-3), but as expected U3-55k did not interact with a sub-fragment consisting of the Box C'/D motif (composed of U3 Box C', Box D and flanking stems; Fig. 4, lanes 7-9). A sub-fragment containing Box B, Box C and the adjacent stem regions of U3 RNA was co-immunoprecipitated with alphaU3-55k antibodies (Fig. 4, lanes 4-6) indicating that the Box B/C motif is sufficient for interaction with U3-55k in vivo.
###end p 48
###begin title 49
###xml 34 42 34 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Interaction of U3-55k with U3 RNA in vitro
###end title 49
###begin p 50
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 94 95 94 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f3">3</xref>
###xml 105 111 105 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 196 204 196 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c29">29</xref>
###xml 358 366 358 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 382 390 382 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 456 463 456 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 621 622 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f5">5</xref>
###xml 846 847 834 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f5">5</xref>
###xml 934 935 922 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f5">5</xref>
We have found that Box B and Box C are each necessary for interaction of U3-55k in vivo (Fig. 3). Lubben et al. reported that interaction of a complex of proteins that included U3-55k with U3 RNA in vitro required a region of the RNA containing both Box B and Box C (29). Interestingly, we found that Box C is the primary determinant of U3-55k binding in an in vitro binding assay. In vitro translated, radiolabeled hU3-55k was incubated with biotinylated Xenopus U3 RNA, the RNA was selected using streptavidin beads and the association of U3-55k was assessed by fluorography. We found that U3-55k bound to U3 RNA (Fig. 5A). While only a small fraction (approximately0.5%) of the U3-55k added to the reaction was co-precipitated, the interaction was reproducible and specific to U3. U3-55k did not interact with U8, another Box C/D snoRNA (Fig. 5A and B, lanes 7 and 4, respectively). The amount of U3-55k observed with U8 in Figure 5A (lane 7) was similar to that bound to streptavidin beads alone (data not shown).
###end p 50
###begin p 51
###xml 70 78 70 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f5">5</xref>
###xml 367 368 367 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f5">5</xref>
###xml 423 431 423 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 512 513 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f5">5</xref>
###xml 581 589 581 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1001 1007 1001 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 768 773 <span type="species:ncbi:4565">wheat</span>
###xml 1001 1007 <span type="species:ncbi:110766|species:ncbi:562">E.coli</span>
Furthermore, we have found that the interaction of U3-55k with U3 RNA in vitro depends upon specific sequences in U3. Substitution of Boxes A, C' and D of U3 did not reduce the association of U3-55k with the RNA (Fig. 5A). However, mutation of Box C eliminated the interaction of U3-55k with the U3 RNA, reducing it to the background level observed with U8 RNA (Fig. 5A). Disruption of Box B did not prevent U3-55k binding in vitro, but did appear to reduce binding relative to wild-type and other mutants (Fig. 5A). Our results indicate that the interaction of U3-55k with U3 RNA in vitro depends predominantly on Box C and to a lesser extent on Box B of U3. While it is important to note that we cannot exclude the possibility that protein components present in the wheat germ extract used to generate the U3-55k protein contributed to the U3 RNA binding, our results may indicate that U3-55k interacts directly with U3 RNA. Assessment of direct binding of purified, recombinant U3-55k expressed in E.coli to U3 RNA was not possible due to the insolubility of the protein under all tested conditions.
###end p 51
###begin p 52
###xml 98 106 98 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 239 247 239 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f5">5</xref>
###xml 531 538 531 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
We tested the ability of U3-55k to interact with fragments of U3 RNA containing the Box B/C motif in vitro. Both the 3' domain of U3 and a sub-fragment comprised of Box B, Box C and flanking stem sequences were bound by the U3-55k protein in vitro (Fig. 5B). The interactions with the fragments appeared to be reduced relative to wild-type U3 but were substantially greater than the background observed with U8 RNA. In summary, our results suggest that the Box B/C motif of U3 is necessary and sufficient for interaction of U3-55k in vivo, but that Box C may be a primary determinant of the interaction.
###end p 52
###begin title 53
Analysis of U3-55k sequences required for nucleolar localization and association with U3 RNA
###end title 53
###begin p 54
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
Previous work indicated that replacement of 17 amino acids at the C-terminus of hU3-55k (with 15 vector-encoded amino acids) disrupted interaction of U3-55k with U3 RNA and resulted in loss of localization of U3-55k to the nucleolus (45). Deletion of 45 amino acids from the N-terminus of the protein, including a putative nuclear localization sequence, did not prevent interaction with U3 or nucleolar localization of the protein (45). We have further investigated the role of hU3-55k sequences in these two processes in experiments using VSV-tagged hU3-55k deletion mutants (Fig. 6A) expressed in transfected cells.
###end p 54
###begin p 55
###xml 125 126 125 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 303 304 303 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
We first assessed the level of expression of each of the VSV-tagged proteins by western analysis of total extract of 1.0 x 106 transfected COS-1 cells using anti-VSV monoclonal antibodies. The various mutant proteins were found to be expressed at levels comparable to VSV-tagged wild-type hU3-55k (Fig. 6B).
###end p 55
###begin p 56
###xml 305 306 305 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 485 486 485 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 835 836 835 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 958 959 958 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
VSV-tagged wild-type U3-55k interacted with U3 RNA and localized to nucleoli in our experimental system. We have assessed the ability of hU3-55k proteins to interact with U3 RNA by precipitation of the VSV-tagged proteins from transfected cell extracts and northern analysis of co-precipitated RNAs (Fig. 6C). While the VSV protein alone did not co-precipitate U3 RNA (Fig. 6C, lane 5), wild-type VSV-tagged hU3-55k expressed in COS-1 cells associated with U3 snoRNA as expected (Fig. 6C, lane 2). Fibrillarin is also found associated with U3 RNA in these cells (Fig. 6C) and fibrillarin immunoprecipitations were included as positive controls in each of the co-precipitation experiments that will be described. The cellular localization of expressed U3-55k proteins was evaluated by immunofluorescence using anti-VSV antibodies (Fig. 6D). As expected, wild-type VSV-tagged hU3-55k expressed in HEp-2 cells localized to nucleoli similar to fibrillarin (Fig. 6D, panels b and j).
###end p 56
###begin p 57
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 349 350 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 535 536 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 591 592 587 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 717 718 709 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
In order to further assess the role of the C-terminal domain of U3-55k in nucleolar localization and U3 RNA association (45),  two additional C-terminal mutant constructs were analyzed (Fig. 6A). We found that deletion of 17 amino acids at the C-terminus of U3-55k also disrupted U3 RNA binding and U3-55k nucleolar localization (Delta459-475, Fig. 6C and D, lanes 7-9 and panel d, respectively). Though we cannot exclude the possibility that this deletion had global effects on protein folding, the mutant protein was expressed (Fig. 6B) and appeared to accumulate in the nucleoplasm (Fig. 6D, panel d). Deletion of the last nine amino acids did not prevent RNA binding or nucleolar localization (Delta467-475, Fig. 6C and D, lanes 10-12 and panel f, respectively). These results indicate that residues located within amino acids 459-466 of hU3-55k are important for interaction with U3 RNA and localization of U3-55k to the nucleolus.
###end p 57
###begin p 58
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 160 167 160 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f1">1</xref>
###xml 369 370 365 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 150 155 <span type="species:ncbi:4932">yeast</span>
A glutamic acid-rich region was previously noted near the N-terminus of the hU3-55k protein sequence (45). This region appears to be conserved in the yeast and Xenopus proteins (Fig. 1). However, we have found that deletion of these amino acids did not prevent the interaction of the protein with U3 RNA or the localization of U3-55k to the nucleolus (Delta64-74, Fig. 6C and B, lanes 13-15 panel h, respectively).
###end p 58
###begin p 59
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c49">49</xref>
###xml 451 452 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 765 766 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 1038 1039 1026 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 1209 1216 1197 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
WD domains like those found in U3-55k have been characterized to be important for dynamic protein-protein interactions (49). We were interested to assess whether the WD repeats of U3-55k are important for association of the protein with U3 snoRNA and localization of the protein to nucleoli. Three deletion mutants were tested: Delta193-352 lacking WD repeats 2-5, Delta193-315 lacking WD repeats 2-4 and Delta140-230 lacking WD repeats 1 and 2 (Fig. 6A). The effects of the deletions on the overall structure of the protein are not known but did not prevent accumulation or nuclear import of the mutant proteins. Though each of the WD deletion mutants was expressed in the transfected cells, U3 RNA was not found in association with any of the three mutants (Fig. 6B and C, lanes 6-8 and lanes 16-24, respectively). Co-precipitation of U3 was not detected even upon a 20-fold increased exposure of the northern blot (data not shown). In addition, the WD deletion mutants accumulated in the nucleus but did not localize to nucleoli (Fig. 6D, panels l, n and p). The results suggest that the WD domains of U3-55k are required for association of U3-55k with U3 snoRNA and for localization of U3-55k to nucleoli in vivo.
###end p 59
###begin title 60
DISCUSSION
###end title 60
###begin p 61
A detailed understanding of the composition and organization of the U3 snoRNP complex is required in order to understand U3 RNP biogenesis, transport and function. Little information is available regarding the nature of the association of either the common Box C/D-associated proteins or the U3-specific proteins with U3 RNA. In this study, we have identified sequence domains in both the U3 RNA and U3-55k protein that are required for their association.
###end p 61
###begin p 62
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c49">49</xref>
###xml 361 368 361 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 375 376 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 478 485 478 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 571 579 571 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 885 886 885 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 1013 1020 1013 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
The predominant sequence feature of U3-55k is a series of six WD repeats. WD repeats within a protein are generally thought to mediate dynamic protein-protein interactions and to provide a platform for the assembly of multicomponent complexes (49). We found that disruption of the WD repeats of U3-55k resulted in loss of association of the protein with U3 RNA in vivo (Fig. 6C) suggesting that protein-protein interactions play an important role in the protein-RNA association in vivo. At the same time, our finding that recombinant U3-55k protein interacts with U3 RNA in vitro suggests that U3-55k may interact directly with U3 RNA. The U3-55k protein sequence does not possess any recognizable RNA binding motifs, but may contain an undefined RNA-binding domain [possibly including the sequences in the C-terminus of U3-55k that we found to be required for U3 snoRNA binding (Fig. 6C)]. Conceivably, U3-55k interacts directly with U3 RNA and the interaction is strengthened by association with other proteins in vivo.
###end p 62
###begin p 63
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f3">3</xref>
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f5">5</xref>
###xml 369 377 369 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c29">29</xref>
###xml 484 491 484 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 497 505 497 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 512 513 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f3">3</xref>
###xml 518 519 518 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f5">5</xref>
###xml 554 561 554 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 660 668 660 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
The interaction of the U3-55k protein with U3 RNA in vivo and in vitro depends upon conserved sequences in an RNA motif that is specific to U3, the Box B/C motif (Figs 3-5). Our findings are in good agreement with a previous study which demonstrated that a region of hU3 (nt 97-204) including Boxes B and C supported the assembly of a complex which included CHO U3-55k in vitro (29). We found that mutation of Box B disrupted the interaction of U3-55k with U3 RNA to a greater extent in vivo than in vitro (Figs 3 and 5). The greater importance of Box B in vivo may reflect the importance of another protein located at Box B (which is absent or limited in the in vitro assay) in the interaction of U3-55k with U3. One model consistent with our results is that U3-55k interacts primarily with Box C of U3 RNA and that the interaction is stabilized by association with other proteins (mediated by the WD repeats of U3-55k) that bind Box B.
###end p 63
###begin p 64
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c40">40</xref>
###xml 321 328 321 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 188 193 <span type="species:ncbi:4932">yeast</span>
###xml 205 210 <span type="species:ncbi:9606">human</span>
###xml 224 229 <span type="species:ncbi:4932">yeast</span>
###xml 399 404 <span type="species:ncbi:9606">human</span>
It is noteworthy that U3 snoRNA associates with two WD repeat proteins, U3-55k and Sof1. Sof1 was identified as a high copy supressor that overcomes the temperature sensitive phenotype of yeast expressing human, rather than yeast, fibrillarin and, like U3-55k, interacts specifically with U3 RNA (40). We have cloned the Xenopus (A.A.Lukowiak, S.Mattox, R.Terns and M.P.Terns, unpublished data) and human (S.Granneman and W.J.van Venrooij, unpublished data) Sof1 homologs and also plan to characterize the manner in which this WD repeat protein is recruited into U3 snoRNP complexes.
###end p 64
###begin p 65
###xml 83 91 83 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c34">34</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c67">67</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c68">68</xref>
###xml 671 672 671 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f5">5</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c29">29</xref>
There is evidence that fibrillarin also requires Box C for association with U3 RNA in vitro and in vivo (34,67, W.Speckmann, R.Terns and M.P.Terns, unpublished data). It is possible that fibrillarin interacts with U3 RNA through association with U3-55k (or another associated protein). On the other hand, a recent study indicates that fibrillarin interacts directly, and in the absence of other proteins, with another Box C/D snoRNA, U16 (68), raising the interesting question whether U3-55k and fibrillarin interact simultaneously or exclusively with U3 RNA. This work and another study indicate that U3-55k can associate with U3 RNA in the absence of fibrillarin (Fig. 5; 29).
###end p 65
###begin p 66
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f2">2</xref>
###xml 215 216 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c45">45</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c31">31</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c69">69</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c70">70</xref>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c30">30</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c31">31</xref>
###xml 900 901 900 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd539f6">6</xref>
U3 RNA is predominantly found within the nucleoli of various cell types where it functions in rRNA processing. It is now clear that U3-55k is also localized in the nucleoli of multiple cell types (Figs 2B and C and 6D; 45). The sequence elements involved in the localization of U3 RNA to nucleoli have been investigated (31,69,70). We have found that while the Box B/C motif of U3 is involved in the retention of the RNA in the nucleus, it is neither required nor sufficient for nucleolar localization (30,31). Thus, U3-55k may function as part of the redundant mechanisms for nuclear retention of U3, but probably does not play a role in the targeting of U3 RNA to nucleoli. Indeed, U3-55k probably relies on interaction with U3 for its own localization to the nucleolus. We observed a correlation between the ability of U3-55k variants to interact with U3 RNA and to be localized to nucleoli (Fig. 6). Mutants that were not able to interact with U3 also did not localize to nucleoli. Thus, U3-55k may be targeted to nucleoli via interaction with the U3 snoRNP.
###end p 66
###begin p 67
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c23">23</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd539c27">27</xref>
###xml 509 511 509 511 <bold xmlns:xlink="http://www.w3.org/1999/xlink"> (</bold>
###xml 102 107 <span type="species:ncbi:4932">yeast</span>
###xml 376 381 <span type="species:ncbi:4932">yeast</span>
It will be important to determine the role of U3-55k in U3 snoRNP biogenesis and function. Studies in yeast have indicated that the Box B/C motif (i.e. the U3-55k binding site) is not essential for stability of U3 RNA but is essential for viability, indicating an important role for the Box B/C motif in U3 snoRNP function (23,27). Correspondingly, it has been found that the yeast U3-55k homolog (Rrp9p) is also not required for the stability of U3 RNA, but is essential for viability and 18S rRNA production (J.Venema and H.A.Raue, personal communication). Future work will further investigate the role of U3-55k in rRNA processing by the U3 snoRNP.
###end p 67
###begin title 68
Figures and Tables
###end title 68
###begin p 69
###xml 14 22 14 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X.laevis</italic>
###xml 120 128 120 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X.laevis</italic>
###xml 149 173 149 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 609 615 609 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 14 22 <span type="species:ncbi:8355">X.laevis</span>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 45 50 <span type="species:ncbi:4932">yeast</span>
###xml 120 128 <span type="species:ncbi:8355">X.laevis</span>
###xml 135 140 <span type="species:ncbi:9606">human</span>
###xml 149 173 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
 Alignment of X.laevis U3-55k with human and yeast homologs. An alignment between the predicted amino acid sequences of X.laevis (Xl), human (h) and Saccharomyces cerevisiae (Sc) U3-55k was generated using PILEUP from the GCG Wisconsin Sequence Analysis package (Version 10). Residues that are identical in two sequences are in black boxes; similar residues are in gray boxes. WD repeat motifs were identified using the Protein Structure Analysis server at the BioMolecular Engineering Research Center (http://BMERC-www.bu.edu/ ) and are indicated with brackets. The glutamic acid-rich region defined by Pluk et al. (45) is indicated with a bar (E-rich region).
###end p 69
###begin p 70
###xml 60 67 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 146 147 146 147 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 190 197 190 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 444 451 428 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 476 477 460 461 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 483 490 467 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 505 506 489 490 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
 Antibodies against U3-55k recognize a nucleolar protein in Xenopus cells. Polyclonal antibodies were raised against recombinant Xenopus U3-55k. (A) Immunoblot analysis of extract from five Xenopus oocyte nuclei was performed using pre-immune sera (lane 1) or affinity purified alphaU3-55k antibodies (lane 2). The arrow indicates the primary band corresponding to an approximately60 kDa protein. Immunofluorescence analysis was carried out on Xenopus oocyte nuclear spreads (B) and Xenopus kidney cells (C). Differential interference contrast (DIC, panels a and c) and fluorescence (panels b and d) microscopy images are shown for each experiment. Representative nucleolar structures are indicated with arrowheads. Samples were analyzed using pre-immune (panel d) and affinity purified alphaU3-55k (panel b) antibodies.
###end p 70
###begin p 71
###xml 64 71 64 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 73 81 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 95 97 95 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 191 198 191 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
 Boxes B and C of U3 snoRNA are required for U3-55k association in vivo. In vitro transcribed, 32P-labeled U3 and U8 snoRNAs, U1 and U6 snRNAs and 5S rRNA were co-injected into the nuclei of Xenopus oocytes. After 4 h, complexes were immunoprecipitated using alphaU3-55k antibodies and co-immunoprecipiated RNAs were isolated from both pellet (P) and supernatant (S) fractions and analyzed by gel electrophoresis and autoradiography. For each experiment, 100% of the pellet (P) and 50% of the total (T) and supernatant (S) samples were analyzed. Immunoprecipitation using pre-immune serum is shown in lanes 1-3. Immunoprecipitation, using alphaU3-55k antibodies with wild-type and variant U3 snoRNAs are shown in lanes 4-27. The positions of the conserved sequence elements are indicated on the U3 RNA secondary structure model diagram.
###end p 71
###begin p 72
###xml 85 92 85 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 94 96 94 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 191 198 191 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 357 364 353 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
 Fragment of U3 snoRNA containing Boxes B and C is sufficient for U3-55k association in vivo. 32P-labeled U3 snoRNA fragments and U1 snRNA (negative control) were injected into the nuclei of Xenopus oocytes and tested for co-immunoprecipitation with alphaU3-55k antibodies as described in Figure 3. The B/C sub-fragment undergoes limited 3'-end trimming in Xenopus oocytes (30). The sub-fragments of U3 snoRNA are shown schematically above each panel.
###end p 72
###begin p 73
###xml 55 63 55 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 65 73 65 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 86 88 86 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">35</sup>
###xml 119 127 119 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 492 493 492 493 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 668 669 648 649 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
 Box C of U3 snoRNA is required for U3-55k association in vitro. In vitro translated, 35S-labeled hU3-55k was added to in vitro transcribed, UTP-21-biotin-labeled RNA. The mixture was incubated for 1 h and biotinylated RNAs were selected from the mixture with streptavidin agarose beads. hU3-55k associated with the biotinylated RNA was eluted by boiling in SDS loading buffer and analyzed by SDS-PAGE and fluorography. Biotinylated RNAs used in each reaction are indicated above each lane. (A) Evaluation of U3-55k association with wild-type (lane 1) and mutant (DeltaA, DeltaC', DeltaB, DeltaC and DeltaD, lanes 2-6, respectively) U3 snoRNA as well as U8 (lane 7). (B) Evaluation of U3-55k association with U3 snoRNA 3' domain and Box B/C sub-fragments (lanes 2 and 3). Wild-type U3 and U8 are shown in lanes 1 and 4.
###end p 73
###begin p 74
###xml 101 102 101 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 415 416 415 416 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 817 818 793 794 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 1337 1338 1305 1306 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 233 238 <span type="species:ncbi:9606">human</span>
###xml 889 894 <span type="species:ncbi:9606">human</span>
 U3-55k sequences required for association with U3 RNA and localization of U3-55k to the nucleolus. (A) The positions of the VSV tag, nuclear localization signals, glutamic acid-rich region and WD repeats in the VSV-tagged wild-type human U3-55k protein (VSV-55k) are represented with boxes. Regions of the protein deleted in each of the mutant constructs analyzed in this work are represented with zig-zag lines. (B) Expression levels of hU3-55k deletion mutants. Western blots using anti-VSV antibodies are shown for COS-1 cells expressing untagged hU3-55k (lane 2), VSV-tagged wild-type U3-55k (lane 1) and deletion constructs Delta459-475 (lane 3), Delta467-475 (lane 4), Delta64-74 (lane 5), Delta140-230 (lane 6), Delta193-315 (lane 7) and Delta193-352 (lane 8). Lanes 3 and 5 are taken from a different blot. (C) The effect of hU3-55k deletions on U3 snoRNP association. VSV-tagged human U3-55k wild-type and deletion constructs were expressed in COS-1 cells and complexes containing the tagged proteins (or endogenous fibrillarin) were immunoprecipitated using alphaVSV (or alphaFib) antibodies. Co-immunoprecipitated U3 RNA was detected by northern blotting. Co-immunoprecipitation of U3 with fibrillarin is shown for each experiment. The input lanes contain 10% of RNA isolated from extracts prepared for immunoprecipitation. (D) Cellular localization of hU3-55k wild-type and deletion mutants. VSV-tagged U3-55k wild-type and deletion constructs were expressed in HEp-2 cells and the localization of the tagged proteins (or endogenous fibrillarin) was assessed by immunofluorescence using alphaVSV (panels c-p) [or alphaFib (panels a and b)] antibodies. Phase contrast (panels a, c, e, g, i, k, m and o) and fluorescence (panels b, d, f, h, j, l, n and p) microscopy images are shown for each experiment. Fibrillarin is found primarily in the phase-dark nucleoli of HEp-2 cells (panels a and b). VSV-tagged wild-type U3-55k (panels i and j) and deletion constructs Delta467-475 (panels e and f) and Delta64-74 (panels g and h) were localized to nucleoli. Deletion mutants Delta459-475 (panels c and d), Delta140-230 (panels k and l), Delta193-315 (panels m and n) and Delta193-352 (panels o and p) did not localize to nucleoli but accumulated in the nucleoplasm.
###end p 74
###begin title 75
ACKNOWLEDGEMENTS
###end title 75
###begin p 76
###xml 81 88 81 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
We kindly thank K. M. Pollard (Scripps Research Institute, La Jolla, CA) for the Xenopus cell line (XlK2) and Antoon Huiskens (University of Nijmegen, Nijmegen, The Netherlands) for his expert technical assistance. This work was supported by the National Institutes of Health (GM54682 to M.P.T.) and The Netherlands Research Council for Chemical Sciences (NWO-CW, grant 97-033 to W.J.v.V.). A.A.L. was supported by a training grant (GM07103) from the National Institutes of Health.
###end p 76
###begin title 77
REFERENCES
###end title 77

